Literature DB >> 24738973

Intragenic CAMTA1 deletions are associated with a spectrum of neurobehavioral phenotypes.

M Shinawi1, R Coorg, J S Shimony, D K Grange, H Al-Kateb.   

Abstract

Intragenic copy number variations involving the CAMTA1 (calmodulin-binding transcription activator 1) gene have recently been reported in four unrelated families with intellectual disability (ID), ataxia, behavioral- and cerebellar-abnormalities. We report a detailed phenotypic and molecular characterization of three individuals with novel intragenic CAMTA1 deletions from two unrelated families and compare the findings to those of previously reported patients. Our patients had deletions of exons 6-11 and presented with ID, developmental delay (DD), attention deficit hyperactivity disorder (ADHD) and constipation. Two individuals from one family had also unsteady gait. Consistent phenotypes associated with CAMTA1 intragenic rearrangements include ID, speech problems and some dysmorphic features whereas neurobehavioral abnormalities are variable. We did not observe obvious phenotypic differences between patients with in-frame and those with frameshift rearrangements. There is an increased evidence that CAMTA1 has a role in brain and cerebellar function. CAMTA1 should be added to the growing list of genes associated with ID/DD, especially when behavioral problems, cerebellar signs, and/or dysmorphism are also present.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CAMTA1; chromosomal; clinical genetics; deletions; microarray; neurobehavioral abnormalities

Mesh:

Substances:

Year:  2014        PMID: 24738973     DOI: 10.1111/cge.12407

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  8 in total

1.  Novel Nonsense Calmodulin-Binding Transcription Activator 1 Mutation Presenting as a Tremor-Predominant Phenotype.

Authors:  Shashank Agarwal; Rebecca Gilbert; Heather A Lau
Journal:  Mov Disord Clin Pract       Date:  2016-03-11

2.  Sparse multiple factor analysis to integrate genetic data, neuroimaging features, and attention-deficit/hyperactivity disorder domains.

Authors:  Natàlia Vilor-Tejedor; Silvia Alemany; Alejandro Cáceres; Mariona Bustamante; Marion Mortamais; Jesús Pujol; Jordi Sunyer; Juan R González
Journal:  Int J Methods Psychiatr Res       Date:  2018-08-14       Impact factor: 4.035

3.  Multidimensional Genetic Analysis of Repeated Seizures in the Hybrid Mouse Diversity Panel Reveals a Novel Epileptogenesis Susceptibility Locus.

Authors:  Russell J Ferland; Jason Smith; Dominick Papandrea; Jessica Gracias; Leah Hains; Sridhar B Kadiyala; Brittany O'Brien; Eun Yong Kang; Barbara S Beyer; Bruce J Herron
Journal:  G3 (Bethesda)       Date:  2017-08-07       Impact factor: 3.154

4.  Developmental cannabidiol exposure increases anxiety and modifies genome-wide brain DNA methylation in adult female mice.

Authors:  Nicole M Wanner; Mathia Colwell; Chelsea Drown; Christopher Faulk
Journal:  Clin Epigenetics       Date:  2021-01-06       Impact factor: 6.551

5.  Myoclonic dystonia phenotype related to a novel calmodulin-binding transcription activator 1 sequence variant.

Authors:  Ivana Dzinovic; Tereza Serranová; Clement Prouteau; Estelle Colin; Alban Ziegler; Juliane Winkelmann; Robert Jech; Michael Zech
Journal:  Neurogenetics       Date:  2021-03-06       Impact factor: 2.660

6.  Association of a Locus in the CAMTA1 Gene With Survival in Patients With Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Isabella Fogh; Kuang Lin; Cinzia Tiloca; James Rooney; Cinzia Gellera; Frank P Diekstra; Antonia Ratti; Aleksey Shatunov; Michael A van Es; Petroula Proitsi; Ashley Jones; William Sproviero; Adriano Chiò; Russell Lewis McLaughlin; Gianni Sorarù; Lucia Corrado; Daniel Stahl; Roberto Del Bo; Cristina Cereda; Barbara Castellotti; Jonathan D Glass; Steven Newhouse; Richard Dobson; Bradley N Smith; Simon Topp; Wouter van Rheenen; Vincent Meininger; Judith Melki; Karen E Morrison; Pamela J Shaw; P Nigel Leigh; Peter M Andersen; Giacomo P Comi; Nicola Ticozzi; Letizia Mazzini; Sandra D'Alfonso; Bryan J Traynor; Philip Van Damme; Wim Robberecht; Robert H Brown; John E Landers; Orla Hardiman; Cathryn M Lewis; Leonard H van den Berg; Christopher E Shaw; Jan H Veldink; Vincenzo Silani; Ammar Al-Chalabi; John Powell
Journal:  JAMA Neurol       Date:  2016-07-01       Impact factor: 29.907

Review 7.  Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma.

Authors:  John M Lamar; Vijeyaluxmy Motilal Nehru; Guy Weinberg
Journal:  Cancers (Basel)       Date:  2018-07-10       Impact factor: 6.639

8.  TDP-43 enhances translation of specific mRNAs linked to neurodegenerative disease.

Authors:  Nagammal Neelagandan; Giorgio Gonnella; Stefan Dang; Philipp C Janiesch; Katharine K Miller; Katrin Küchler; Rita F Marques; Daniela Indenbirken; Malik Alawi; Adam Grundhoff; Stefan Kurtz; Kent E Duncan
Journal:  Nucleic Acids Res       Date:  2019-01-10       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.